Anthropic closed its first day on Nasdaq at $97.17 on Thursday, up 17.1% from its $83 IPO price but well below the morning's highs. The Claude developer kept a sizeable debut gain even as the enthusiasm that briefly pushed its reported fully diluted valuation above $2 trillion faded.
Shares opened at $111.50 and reached $115.10 before dropping as low as $92.72. By the closing bell, ANT was down 12.9% from its opening trade and 15.6% from its high, according to Google Finance's closing quote and the day's trading range.
An $81.34 billion offering gets bigger
Anthropic's official pricing announcement put the offer at $83 a share, above the earlier $70-$78 range. The company also increased the number of shares offered to 980 million from the 825 million set out in its preliminary filing.
At that price, the public offering totals $81.34 billion before fees. Anthropic is selling 956,351,354 new shares, while existing holders are selling another 23,648,646. The company won't receive the money from those shareholders' sales.
Underwriters have a 30-day option to buy up to another 147 million shares. The transaction is expected to close November 20, subject to the usual closing conditions.
A separate private placement adds to the financing. The company's preliminary prospectus describes $26 billion of Class N stock to be sold at the IPO price. That placement is contingent on the public offering and other conditions, with completion scheduled immediately afterward.
Together, the public offering and planned placement amount to $107.34 billion before fees. The jump in the traded share price raises the company's valuation further, rather than increasing the proceeds from shares already priced at $83.
Retail demand had been building before trading began
As previously reported by Apex in the article below, Vanda Research forecast about $250 million in first-day net retail buying ahead of the listing. That would be more than twice the $118 million recorded during SpaceX's June debut.
The closing price leaves two very different first-day experiences. Investors allocated shares at $83 finished $14.17 a share ahead. Someone who bought at the $111.50 opening price and held through the close was down $14.33 a share. Demand was strong enough to support a gain over the offer price, but buyers who chased the opening jump paid for it.
The roughly $2 trillion opening valuation used a fully diluted share count, including potential shares as well as stock already outstanding. The subsequent pullback means that opening figure no longer describes where the shares finished the session.
Dario puts science and safety at the center of the debut
CEO Dario Amodei used Thursday's listing-day remarks to describe what he hopes the company can build with its stronger financial position. He pointed to medicine as one of the clearest opportunities:
I believe sufficiently powerful AI, working in concert with humans, could compress a century of scientific and medical progress into a decade.
Dario stressed that the work was still at an early stage and that experiments and clinical trials would take time. He also said the company's approach to safety would continue to govern when it trains and releases systems:
And to state it unequivocally, we will pace the training and deployment of AI systems, taking as long as is necessary to have confidence that they are safe and will remain under human control. We will not bend to either business or political pressure.
The business is growing quickly. Anthropic's IPO materials report third-quarter revenue of $17 billion, more than 12 times the year-earlier level, and over 11,900 customers generating at least $100,000 each in trailing annual revenue.
Those materials also show a $23.3 billion quarterly net loss, including a $21.9 billion noncash charge tied to changes in the value of convertible instruments. Anthropic now has to deliver on that growth as a public company, with investors able to put a fresh price on its progress every trading day.